Prevalencia de derrame pericárdico en enfermedades sistémicas

Oscar Orihuela-Rodríguez1, Héctor Carmona-Ruiz1

  • 1Instituto Mexicano del Seguro Social, Centro Médico Siglo XXI, Hospital de Especialidades, Ciudad de México, México.

Gaceta Medica De Mexico
|June 21, 2019
PubMed

Insights

Pericardial effusion, fluid in the heart sac, affects 3.5% of patients with systemic diseases. Uremic causes were most common, with moderate to severe effusions frequent.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Diagnostic Imaging

Background:

  • Pericardial effusion is defined as 50 mL or more of fluid in the pericardial sac.
  • Systemic diseases are frequently associated with pericardial effusion.

Purpose of the Study:

  • To determine the prevalence of pericardial effusion in patients diagnosed with systemic diseases.
  • To analyze the etiological factors and severity of pericardial effusion in this population.

Main Methods:

  • Retrospective review of 10,653 echocardiographic studies conducted between 2006 and 2016.
  • Classification of pericardial effusion severity (mild, moderate, severe) based on Weitzman's criteria (mm).

Main Results:

  • A prevalence of 3.5% (380 cases) of pericardial effusion was identified.
  • Uremic etiology was the most frequent cause (59.7%), followed by reduced lymphatic drainage (15.8%).
  • Effusions were predominantly of moderate (38.7%) and severe (38.4%) classification.

Conclusions:

  • The study confirms a 3.5% prevalence of pericardial effusion among patients with systemic diseases.
  • Understanding the etiology and severity is crucial for managing these patients effectively.
Abstract

Related Concept Videos

Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.7K
Behavior of Gas Molecules: Molecular Diffusion, Mean Free Path, and Effusion03:48

Behavior of Gas Molecules: Molecular Diffusion, Mean Free Path, and Effusion

Although gaseous molecules travel at tremendous speeds (hundreds of meters per second), they collide with other gaseous molecules and travel in many different directions before reaching the desired target. At room temperature, a gaseous molecule will experience billions of collisions per second. The mean free path is the average distance a molecule travels between collisions. The mean free path increases with decreasing pressure; in general, the mean free path for a gaseous molecule will be...
31.2K
Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
4.1K
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
695